Biotech/Chemical Patents: Sections 101,102,103 | On-Demand Webinar

Overcoming Sections 101,102, 103 Conundrum for Biotech and Chemical Patents: Practical Guide in 2020 | On-Demand Webinar

Broadcast Date: Tuesday, January 14, 2020 from 3:00 pm to 4:30 pm (ET)

In recent years, the hope on solving the patent eligibility conundrum is still up in the air. Precedential decisions interpreting and applying Section 101 from both the Supreme Court and the Federal Circuit created tangled patent eligibility rulings that have limited the ability to patent certain technologies. In connection with this, earlier this year, the members of the Senate Judiciary Subcommittee on Intellectual Property, along with members of the House, have produced a draft bill that will revise 35 U.S.C. Section 101. However, this draft bill is not yet available for there are still a lot of details to be discussed, and the proposed legislation is still to be determined.  A mutual effort to produce a consistent subject matter eligibility framework is both an achievement and a raising opportunity for the year ahead.

In this LIVE Webcast, IP attorneys Leslie Kushner (Pearl Cohen) and Brendan Gavin (White & Case) will provide and present an in-depth analysis of the fundamentals as well as recent developments in Overcoming Sections 101,102, 103 Conundrum for Biotech and Chemical Patents. Speakers will also present all the important issues surrounding this significant topic including its impact on Biotech and Chemical Patents.

Key Topics:

• Guiding Principles for Patent Eligibility
• Updated Framework for Patent Eligibility
• Section 101, 102, & 103 Conundrums
• Impacts on Biotech and Chemical Patent
• What Lies Ahead